Treatment of Myocardium avium complex infection: does the beige mouse model predict therapeutic outcome in humans?

J Infect Dis. 1996 Mar;173(3):750-3. doi: 10.1093/infdis/173.3.750.

Abstract

To determine the predictive value of a standard murine model in the treatment of disseminated Myocardium avium complex (MAC) infection, beige mice were infected with MAC strains isolated from human immunodeficiency virus-infected patients and treated with the same antibiotic (ethambutol, clofazimine, or rifampin) that had been administered to the subject from whom that strain had been recovered. While ethambutol had the greatest bacteriologic efficacy in humans (mean decrease +/-SD, 1.0+/-0.5 log 10 cfu/mL of blood), clofazimine had the greatest bacteriostatic efficacy in mice (mean decrease +/- SD, 2.8 +/- 0.7 log(10) cfu/g of tissue). A linear correlation was not observed between bacteriostatic activity in mouse liver or spleen and the degree of bacteriologic response in humans (P > or = to .1). Odds ratios for a response in humans based on a bacteriologic response in mice were not significant for each agent (P > or = to .1, all cases).

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS-Related Opportunistic Infections / complications
  • AIDS-Related Opportunistic Infections / drug therapy
  • AIDS-Related Opportunistic Infections / microbiology
  • Animals
  • Antitubercular Agents / therapeutic use*
  • Clofazimine / therapeutic use
  • Colony Count, Microbial
  • Disease Models, Animal
  • Ethambutol / therapeutic use
  • Humans
  • Liver / microbiology
  • Mice
  • Mycobacterium avium-intracellulare Infection / complications
  • Mycobacterium avium-intracellulare Infection / drug therapy*
  • Mycobacterium avium-intracellulare Infection / microbiology
  • Rifampin / therapeutic use
  • Species Specificity
  • Spleen / microbiology

Substances

  • Antitubercular Agents
  • Ethambutol
  • Clofazimine
  • Rifampin